---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-27T14:11:48.759975'
end_time: '2025-12-27T14:16:39.872167'
duration_seconds: 291.11
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: RAB9B
  gene_symbol: RAB9B
  uniprot_accession: Q9NP90
  protein_description: 'RecName: Full=Ras-related protein Rab-9B; EC=3.6.5.2 {ECO:0000250|UniProtKB:P62820};
    AltName: Full=Rab-9-like protein; Short=Rab-9L;'
  gene_info: Name=RAB9B {ECO:0000312|HGNC:HGNC:14090}; Synonyms=RAB9L;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the small GTPase superfamily. Rab family.
  protein_domains: P-loop_NTPase. (IPR027417); Rab9. (IPR041824); Small_GTP-bd. (IPR005225);
    Small_GTPase. (IPR001806); Ras (PF00071)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 15
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9NP90
- **Protein Description:** RecName: Full=Ras-related protein Rab-9B; EC=3.6.5.2 {ECO:0000250|UniProtKB:P62820}; AltName: Full=Rab-9-like protein; Short=Rab-9L;
- **Gene Information:** Name=RAB9B {ECO:0000312|HGNC:HGNC:14090}; Synonyms=RAB9L;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small GTPase superfamily. Rab family.
- **Key Domains:** P-loop_NTPase. (IPR027417); Rab9. (IPR041824); Small_GTP-bd. (IPR005225); Small_GTPase. (IPR001806); Ras (PF00071)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RAB9B" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RAB9B' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RAB9B** (gene ID: RAB9B, UniProt: Q9NP90) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9NP90
- **Protein Description:** RecName: Full=Ras-related protein Rab-9B; EC=3.6.5.2 {ECO:0000250|UniProtKB:P62820}; AltName: Full=Rab-9-like protein; Short=Rab-9L;
- **Gene Information:** Name=RAB9B {ECO:0000312|HGNC:HGNC:14090}; Synonyms=RAB9L;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the small GTPase superfamily. Rab family.
- **Key Domains:** P-loop_NTPase. (IPR027417); Rab9. (IPR041824); Small_GTP-bd. (IPR005225); Small_GTPase. (IPR001806); Ras (PF00071)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "RAB9B" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'RAB9B' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **RAB9B** (gene ID: RAB9B, UniProt: Q9NP90) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity check: The target is human RAB9B (UniProt Q9NP90), a small GTPase of the Rab family. Rab9 proteins regulate transport between late endosomes and the trans-Golgi network (TGN). The literature recognizes two human isoforms, Rab9A and Rab9B; most mechanistic work has focused on Rab9A, with functional inferences extended to Rab9B as a close paralog. Where evidence is Rab9A-specific, this is stated, and implications for Rab9B are noted cautiously (ng2012rabgtpasesregulating pages 4-6).

1) Key concepts and definitions with current understanding
- Protein class and domains: RAB9B encodes a small Ras-related GTPase (Rab subfamily) that cycles between GDP- and GTP-bound states to control vesicular trafficking steps. Like other Rabs, its switch I/II regions mediate GTP-dependent effector binding; effector recognition via these regions is exemplified biochemically for Rab9’s interaction with effectors (shown for Rab9A) (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088) (kloer2010assemblyofthe pages 8-9).
- Canonical pathway: Rab9 family GTPases mediate retrograde trafficking from late endosomes to the TGN, classically to recycle cation-independent mannose-6-phosphate receptor (CI-M6PR), which retrieves lysosomal hydrolases. TIP47 acts as a cargo adaptor that binds M6PR cytosolic tails and partners with Rab9; the TGN golgin/tether GCC185 functions as a Rab9 effector to capture incoming vesicles. These functions are well reviewed, establishing the Rab9 pathway’s role in endosome→TGN recycling (Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (ng2012rabgtpasesregulating pages 4-6).
- Subcellular localization: Rab9 family proteins localize to late endosomes and can be detected on lysosomal membranes; perturbation of Rab9A or Rab9B (siRNA) impacts MPR/TGN46 distribution, consistent with roles at the late endosome–TGN interface (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (yoshimura2010familywidecharacterizationof pages 9-10).

2) Recent developments and latest research (prioritize 2023–2024)
- Targeted 2023–2024, human RAB9B-specific primary studies are sparse. Contemporary work continues to place the Rab9 pathway at the center of endosome→TGN sorting, but most new mechanistic dissection still uses Rab9A. Cell-context specificity in innate immunity highlights that Rab9 is recruited to pathogen vacuoles and can modulate antimicrobial trafficking; in macrophages, Rab9 is not required for Rab32/BLOC-3–dependent Salmonella killing, refining older models that placed Rab9 upstream of Rab32 (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8). This underscores pathway rewiring across cell types and cautions against assuming a universal Rab9B role in antimicrobial vacuolar traffic.
- Systems-scale GEF mapping remains a cornerstone for Rab9 paralogs: DENN-domain family screens (including siRNA to Rab9A, Rab9B and DENND2 paralogs) demonstrated effects on MPR distribution and support DENND-family GEFs in the Rab9 axis; these findings continue to guide GEF assignments in current databases and reviews (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (yoshimura2010familywidecharacterizationof pages 9-10).

3) Current applications and real-world implementations
- Lysosome biogenesis and enzyme delivery: Because CI-M6PR recycling determines lysosomal hydrolase trafficking, Rab9 pathway integrity is a practical readout in studies of lysosomal storage and toxin routing. TIP47–Rab9–GCC185 interactions are used experimentally to manipulate retrograde traffic and interpret toxin susceptibility assays that depend on endosome→TGN transport (reviewed in Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (ng2012rabgtpasesregulating pages 4-6).
- Infection biology: In macrophages, Rab9 is recruited to Salmonella-containing vacuoles, but depletion did not impair Rab32/BLOC-3–dependent killing, informing host-directed therapeutic strategies that target distinct Rab circuits without compromising antimicrobial functions (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8).

4) Expert opinions and analysis from authoritative sources
- Effector recognition and specificity: The biochemical paradigm that Rab effectors recognize switch I/II in the GTP-bound state is clearly demonstrated for Rab9A with BLOC-3/HPS4. High-affinity binding (KD ~82 nM for BLOC-3–Rab9A-GTP) indicates a robust effector interaction surface; given the close paralogy, this frames expectations for Rab9B effector engagement, pending direct measurements (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088) (kloer2010assemblyofthe pages 8-9).
- Pathway architecture: Authoritative reviews position Rab9 as central to late endosome–TGN retrograde traffic, coordinating cargo adaptors (TIP47), TGN tethers (GCC185), and SNARE machinery. These analyses remain the standard interpretive framework for Rab9 paralogs including RAB9B (Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (ng2012rabgtpasesregulating pages 4-6).

5) Relevant statistics and data from recent studies
- Effector affinity: BLOC-3 (HPS1–HPS4 heterodimer) binds Rab9A-GTP with KD ≈ 82 ± 11 nM; a truncated BLOC-3 variant binds with KD ≈ 203 ± 15 nM, mapping to Rab9 switch I/II (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088) (kloer2010assemblyofthe pages 8-9).
- Functional depletion outcomes: In HeLa cells, siRNA targeting Rab9A, Rab9B, and DENND2 family members perturbed MPR/TGN46 localization, supporting a role for both Rab9 isoforms in receptor recycling; Rab9-tagged constructs localized to lysosome membranes in these assays (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (yoshimura2010familywidecharacterizationof pages 9-10).
- Pathogen vacuole recruitment: GFP-Rab9 is recruited to Salmonella-containing vacuoles; nonetheless, Rab9 knockdown did not diminish Rab32/BLOC-3–dependent killing in macrophages, indicating pathway divergence by cell type (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8).

Detailed functional annotation for RAB9B (human)
- Primary function: RAB9B is a Rab GTPase implicated in retrograde transport from late endosomes to the TGN, acting in retrieval of CI-M6PR and associated cargo. Core components of this route include the cargo adaptor TIP47 and the TGN tether GCC185; their cooperation facilitates vesicle capture and fusion at the TGN. While most direct mechanistic evidence is for Rab9A, siRNA-based functional data indicate Rab9B participates in the same pathway in human cells (Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827; Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (ng2012rabgtpasesregulating pages 4-6, yoshimura2010familywidecharacterizationof pages 9-10).
- Subcellular localization: Late endosomes/lysosomes and vesicles en route to the TGN; Rab9 family proteins can be visualized on lysosomal membranes and late endosomal carriers in human cells (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051; Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (yoshimura2010familywidecharacterizationof pages 9-10, ng2012rabgtpasesregulating pages 4-6).
- Effectors and regulators:
  • Effectors: TIP47 (cargo adaptor) and GCC185 (TGN tether) are established Rab9 effectors coordinating MPR recycling (Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (ng2012rabgtpasesregulating pages 4-6).
  • BLOC-3 (HPS1–HPS4): Biochemically validated Rab9A effector with high-affinity, GTP-dependent binding via Rab switch I/II. This positions the HPS1/4 complex as a Rab9 pathway effector relevant to lysosome-related organelle biogenesis; applicability to Rab9B is plausible but not yet directly quantified (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088) (kloer2010assemblyofthe pages 8-9).
  • GEFs: Family-wide DENN screens and parallel depletion of DENND2 and Rab9A/B support DENN-domain GEFs acting upstream in the Rab9 axis; specific DENND2 involvement was inferred from MPR redistribution upon knockdown (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (yoshimura2010familywidecharacterizationof pages 9-10).
- Distinctions from RAB9A: Experimental literature is heavily Rab9A-biased; nevertheless, siRNA evidence indicates that Rab9B contributes to the same endosome→TGN pathway in human cells. Cell-type expression differences exist; in macrophages, Rab9b transcripts were reported as barely detected, suggesting tissue/cell-type variability that may underlie experimental dependence on Rab9A versus Rab9B (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024; Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (balci2020varpandrab9 pages 5-8, yoshimura2010familywidecharacterizationof pages 9-10).
- Roles in autophagy/mitophagy: Direct, human RAB9B-specific evidence in 2020–2024 primary literature was not identified in the sources retrieved here. Given the Rab9 pathway’s endolysosomal focus, some reviews discuss potential intersections with degradative pathways, but precise Rab9B roles require more direct study; thus, no specific claim is made here absent primary support (ng2012rabgtpasesregulating pages 4-6).
- Disease/phenotype associations: Rab9 pathway dysfunction affects lysosomal enzyme trafficking and can modulate pathogen handling. In macrophages, Rab9 recruitment to SCVs is evident, but Rab9 is dispensable for Rab32/BLOC‑3–mediated killing, narrowing its disease-relevant role in certain innate contexts (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8). More granular, RAB9B-specific human genetic associations were not supported by the retrieved, citable primary sources.

Limitations and open questions
- The majority of precise biochemical data (e.g., BLOC-3 binding kinetics) are for Rab9A, and high-confidence, Rab9B-specific effector/GEF kinetics remain to be established. Cell-type expression differences (e.g., low Rab9b transcript in macrophages) may produce divergent dependencies across tissues and should be mapped systematically (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8).

Conclusion
Human RAB9B is a Rab family small GTPase that contributes to endosome-to-TGN retrograde trafficking, particularly CI-M6PR recycling, by engaging canonical Rab9 effectors including cargo adaptor TIP47 and the TGN tether GCC185, localizing to late endosomal/lysosomal membranes and retrograde carriers. Rab9 pathway regulation involves DENN-domain GEFs; BLOC-3/HPS4 is a high-affinity Rab9 effector demonstrated for Rab9A and relevant to lysosome-related organelle biogenesis. In innate immune cells, Rab9 is recruited to pathogen vacuoles but is dispensable for Rab32/BLOC-3-dependent killing, emphasizing cell-context specificity. While recent, Rab9B-specific human studies are limited, convergent functional and localization data support a conserved role alongside Rab9A in maintaining lysosomal enzyme recycling and endosomal–Golgi homeostasis (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088; Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051; Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827; Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (kloer2010assemblyofthe pages 8-9, yoshimura2010familywidecharacterizationof pages 9-10, ng2012rabgtpasesregulating pages 4-6, balci2020varpandrab9 pages 5-8).

References

1. (ng2012rabgtpasesregulating pages 4-6): Ee Ling Ng, Bin Qi Gan, Fanny Ng, and Bor Luen Tang. Rab gtpases regulating receptor trafficking at the late endosome–lysosome membranes. Cell Biochemistry and Function, 30:515-523, Aug 2012. URL: https://doi.org/10.1002/cbf.2827, doi:10.1002/cbf.2827. This article has 57 citations and is from a peer-reviewed journal.

2. (kloer2010assemblyofthe pages 8-9): Daniel P. Kloer, Raul Rojas, Viorica Ivan, Kengo Moriyama, Thijs van Vlijmen, Namita Murthy, Rodolfo Ghirlando, Peter van der Sluijs, James H. Hurley, and Juan S. Bonifacino. Assembly of the biogenesis of lysosome-related organelles complex-3 (bloc-3) and its interaction with rab9. Journal of Biological Chemistry, 285:7794-7804, Mar 2010. URL: https://doi.org/10.1074/jbc.m109.069088, doi:10.1074/jbc.m109.069088. This article has 122 citations and is from a domain leading peer-reviewed journal.

3. (yoshimura2010familywidecharacterizationof pages 9-10): Shin-ichiro Yoshimura, Andreas Gerondopoulos, Andrea Linford, Daniel J. Rigden, and Francis A. Barr. Family-wide characterization of the denn domain rab gdp-gtp exchange factors. The Journal of Cell Biology, 191:367-381, Oct 2010. URL: https://doi.org/10.1083/jcb.201008051, doi:10.1083/jcb.201008051. This article has 432 citations.

4. (balci2020varpandrab9 pages 5-8): Arda Balci, Virtu Solano-Collado, Massimiliano Baldassarre, and Stefania Spanò. Varp and rab9 are dispensable for the rab32/bloc-3 dependent salmonella killing. Frontiers in Cellular and Infection Microbiology, Dec 2020. URL: https://doi.org/10.3389/fcimb.2020.581024, doi:10.3389/fcimb.2020.581024. This article has 7 citations and is from a poor quality or predatory journal.

## Citations

1. ng2012rabgtpasesregulating pages 4-6
2. kloer2010assemblyofthe pages 8-9
3. yoshimura2010familywidecharacterizationof pages 9-10
4. https://doi.org/10.1074/jbc.M109.069088
5. https://doi.org/10.1002/cbf.2827
6. https://doi.org/10.1083/jcb.201008051
7. https://doi.org/10.3389/fcimb.2020.581024
8. https://doi.org/10.1002/cbf.2827;
9. https://doi.org/10.1083/jcb.201008051;
10. https://doi.org/10.3389/fcimb.2020.581024;
11. https://doi.org/10.1074/jbc.M109.069088;
12. https://doi.org/10.1002/cbf.2827,
13. https://doi.org/10.1074/jbc.m109.069088,
14. https://doi.org/10.1083/jcb.201008051,
15. https://doi.org/10.3389/fcimb.2020.581024,